Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.
Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.
复制标题
DOI：
10.3390/jpm11121361
复制
发表时间：
2021-12-14
影响因子：
--
通讯作者：
Seewaldt V
中科院分区：
文献类型：
--
作者：
Wright N;Gong Z;Kittles R;Natarajan R;Jovanovic-Talisman T;Rida P;LaBarge M;Seewaldt V
The enigma of why some premalignant or pre-invasive breast lesions transform and progress while others do not remains poorly understood. Currently, no radiologic or molecular biomarkers exist in the clinic that can successfully risk-stratify high-risk lesions for malignant transformation or tumor progression as well as serve as a minimally cytotoxic actionable target for at-risk subpopulations. Breast carcinogenesis involves a series of key molecular deregulatory events that prompt normal cells to bypass tumor-suppressive senescence barriers. Kinesin family member C1 (KIFC1/HSET), which confers survival of cancer cells burdened with extra centrosomes, has been observed in premalignant and pre-invasive lesions, and its expression has been shown to correlate with increasing neoplastic progression. Additionally, KIFC1 has been associated with aggressive breast tumor molecular subtypes, such as basal-like and triple-negative breast cancers. However, the role of KIFC1 in malignant transformation and its potential as a predictive biomarker of neoplastic progression remain elusive. Herein, we review compelling evidence suggesting the involvement of KIFC1 in enabling pre-neoplastic cells to bypass senescence barriers necessary to become immortalized and malignant. We also discuss evidence inferring that KIFC1 levels may be higher in premalignant lesions with a greater inclination to transform and acquire aggressive tumor intrinsic subtypes. Collectively, this evidence provides a strong impetus for further investigation into KIFC1 as a potential risk-stratifying biomarker and minimally cytotoxic actionable target for high-risk patient subpopulations.
登录
查看更多内容
年龄和绕过停滞的手段会影响永生的人类乳腺上皮细胞的内在亚型。
影响因子：
5.5
作者：
Lee JK;Garbe JC;Vrba L;Miyano M;Futscher BW;Stampfer MR;LaBarge MA
通讯作者：
LaBarge MA
ATM 和 ATR 激酶通过靶向 KIFC1 磷酸化来调节中心体聚类和肿瘤复发。
影响因子：
16.6
作者：
Fan G;Sun L;Meng L;Hu C;Wang X;Shi Z;Hu C;Han Y;Yang Q;Cao L;Zhang X;Zhang Y;Song X;Xia S;He B;Zhang S;Wang C
通讯作者：
Wang C
影响因子：
9.2
作者：
Chan JY
通讯作者：
Chan JY
影响因子：
4.3
作者：
Garbe, James C.;Holst, Charles R.;Stampfer, Martha R.
通讯作者：
Stampfer, Martha R.
影响因子：
3.3
作者：
Cai, Shang;Weaver, Lesley N.;Walczak, Claire E.
通讯作者：
Walczak, Claire E.